| Product Code: ETC7551269 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India pneumonia therapeutics market import shipment experienced a negative CAGR from 2020-2024 with a significant decline in growth rate between 2023 and 2024. The market exhibited a slowing trend, indicating reduced momentum and potential stabilization or contraction over the period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Pneumonia Therapeutics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Pneumonia Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 India Pneumonia Therapeutics Market - Industry Life Cycle |
3.4 India Pneumonia Therapeutics Market - Porter's Five Forces |
3.5 India Pneumonia Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Pneumonia Therapeutics Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.7 India Pneumonia Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Pneumonia Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.9 India Pneumonia Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Pneumonia Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pneumonia in India |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of pneumonia |
4.2.3 Government initiatives to improve healthcare infrastructure and access to pneumonia therapeutics |
4.3 Market Restraints |
4.3.1 High cost of pneumonia therapeutics limiting affordability for some patients |
4.3.2 Limited availability of advanced treatment options in certain regions of India |
5 India Pneumonia Therapeutics Market Trends |
6 India Pneumonia Therapeutics Market, By Types |
6.1 India Pneumonia Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Pneumonia Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Pneumonia Therapeutics Market Revenues & Volume, By Bacterial Pneumonia, 2021- 2031F |
6.1.4 India Pneumonia Therapeutics Market Revenues & Volume, By Viral Pneumonia, 2021- 2031F |
6.1.5 India Pneumonia Therapeutics Market Revenues & Volume, By Fungal Pneumonia, 2021- 2031F |
6.2 India Pneumonia Therapeutics Market, By Age Group |
6.2.1 Overview and Analysis |
6.2.2 India Pneumonia Therapeutics Market Revenues & Volume, By Children, 2021- 2031F |
6.2.3 India Pneumonia Therapeutics Market Revenues & Volume, By Adult, 2021- 2031F |
6.2.4 India Pneumonia Therapeutics Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.3 India Pneumonia Therapeutics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Pneumonia Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Pneumonia Therapeutics Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 India Pneumonia Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Pneumonia Therapeutics Market, By Drug Class |
6.4.1 Overview and Analysis |
6.4.2 India Pneumonia Therapeutics Market Revenues & Volume, By Antibiotics, 2021- 2031F |
6.4.3 India Pneumonia Therapeutics Market Revenues & Volume, By Antiviral Drugs, 2021- 2031F |
6.4.4 India Pneumonia Therapeutics Market Revenues & Volume, By Antifungal Drugs, 2021- 2031F |
6.4.5 India Pneumonia Therapeutics Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.4.6 India Pneumonia Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Pneumonia Therapeutics Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Pneumonia Therapeutics Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 India Pneumonia Therapeutics Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 India Pneumonia Therapeutics Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 India Pneumonia Therapeutics Market Import-Export Trade Statistics |
7.1 India Pneumonia Therapeutics Market Export to Major Countries |
7.2 India Pneumonia Therapeutics Market Imports from Major Countries |
8 India Pneumonia Therapeutics Market Key Performance Indicators |
8.1 Number of pneumonia cases diagnosed and treated annually in India |
8.2 Percentage increase in the adoption of new and innovative pneumonia therapeutics |
8.3 Investment in research and development for developing more cost-effective pneumonia treatment options |
9 India Pneumonia Therapeutics Market - Opportunity Assessment |
9.1 India Pneumonia Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Pneumonia Therapeutics Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.3 India Pneumonia Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Pneumonia Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.5 India Pneumonia Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Pneumonia Therapeutics Market - Competitive Landscape |
10.1 India Pneumonia Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 India Pneumonia Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here